Abdominal obesity, typically measured by waist circumference (WC) and waist-hip ratio (WHR), is more closely associated with metabolic dysfunctions that are related to cardiovascular diseases than is general obesity[@b1], which is generally assessed by body mass index (BMI). Previous studies have identified multiple genetic loci associated with WC and WHR[@b2][@b3][@b4][@b5][@b6][@b7][@b8][@b9][@b10][@b11][@b12][@b13]. However, the majority of these studies were conducted in populations of European ancestry or included a limited number of East Asians[@b9]. East Asians tend to have a higher level of abdominal fat, despite relatively low BMI values; and experience a higher metabolic disease risk than European-ancestry individuals with the same BMI level[@b14]. Therefore, it is particularly important to investigate the genetic determinants of abdominal fat, i.e. WC and WHR, in East Asian populations.

We previously reported genetic loci for BMI using data from the Asian Genetic Epidemiology Network (AGEN) Consortium[@b15][@b16]. In this study, we conducted meta-analyses of data from genome-wide association studies (GWAS) of WC and WHR to identify new genetic loci and evaluate associations of previously-identified genetic loci with overall and abdominal obesity in our study populations.

Results
=======

Our initial meta-analysis used two complementary but related measures of abdominal obesity, WC and WHR, as the outcome variables, and analyzed the association of WC and WHR with approximately 2.5 million genotyped or imputed SNPs as well as about 50,000 typed exome-chip variants. The total sample sizes in Stage I were 53,052 for WC and 48,312 for WHR. We selected 33 SNPs at 33 independent loci with *P* \< 1.00 × 10^−6^, based on the GWAS data that were recruited at the first round of Stage I, for a *de novo* replication (Stage II) of associations with WC or WHR. The replication genotyping was conducted at three study sites (see [Supplementary Table 3](#S1){ref-type="supplementary-material"} online) comprising 3,762 to 17,110 Asian-ancestry individuals based on availability of *de novo* data for each SNP. Participating studies are described in the [Supplementary Information](#S1){ref-type="supplementary-material"} and [Supplementary Tables 1](#S1){ref-type="supplementary-material"} to [3](#S1){ref-type="supplementary-material"} online.

The associations of SNPs with WC or WHR were analyzed with or without adjustment for BMI (see Methods), following the common practice employed in published studies[@b2][@b3][@b4][@b5][@b6][@b7][@b8][@b9][@b10][@b11][@b12][@b13]. Thus, there were four traits included in this study: WC with adjustment for BMI (WCadjBMI), WHR with adjustment for BMI (WHRadjBMI), WC without adjustment for BMI (WCnoBMI), and WHR without adjustment for BMI (WHRnoBMI). The results of the initial Stage I and Stage II for the selected 33 SNPs are presented in [Supplementary Table 4](#S1){ref-type="supplementary-material"} online. In [Table 1](#t1){ref-type="table"} (see also [Fig. 1](#f1){ref-type="fig"} and [Supplementary Table 5](#S1){ref-type="supplementary-material"}), we present the newly-identified loci that were associated with WCadjBMI, WHRadjBMI, and WCnoBMI at a genome-wide significance level (*P* \< 5.00 × 10^−8^) based on Stage I data alone or the combined Stage I and Stage II data in Asian-ancestry populations. For WCadjBMI, we have identified four new loci (index SNPs) near these genes: *EFEMP1* (rs3791679, *P* = 4.86 × 10^−14^), *ADAMTSL3* (rs8030379, *P* = 1.62 × 10^−9^), *CNPY2* (rs3809128, *P* = 3.74 × 10^−9^), and *GNAS* (rs2057291, *P* = 4.02 × 10^−8^); for WHRadjBMI, we have identified two loci near the *NID2* (rs1982963, *P* = 1.07 × 10^−14^) and *HLA-DRB5* (rs5020946, *P* = 1.30 × 10^−9^) genes; for WCnoBMI, we have identified three loci near the *CEP120* (rs10051787, *P* = 7.23 × 10^−12^), *TSC22D2* (rs1868673, *P* = 1.49 × 10^−8^), and *SLC22A2* (rs368123, *P* = 2.64 × 10^−8^) genes. In addition, three SNPs near three genes (*ADAMTS3, IHH, QSOX2*) for WCadjBMI, and two SNPs near two genes (*PPAP2B, PACSIN3*) for WHRadjBMI were found to approach the genome-wide significance level (*P* \< 7.56 × 10^−7^) (see [Supplementary Tables 5](#S1){ref-type="supplementary-material"},[6](#S1){ref-type="supplementary-material"},[7](#S1){ref-type="supplementary-material"} online). We requested an *in silico* replication for the 14 SNPs described above in the Genetic Investigation of ANthropometric Traits (GIANT) consortium[@b13]. No data were available for rs3809128 (MAF \< 0.01 in CEU) near *CNPY2* in the GIANT data. As shown in [Supplementary Table 6](#S1){ref-type="supplementary-material"} online, the association directions were consistent for 12 out of the remaining 13 SNPs (*P* = 0.0034 by the binomial test), although the explained variances were generally smaller than those observed in East Asians (see [Supplementary Table 5](#S1){ref-type="supplementary-material"} online). The SNP rs2057291 near *GNAS* exhibited an opposite association direction in the GIANT data. Seven of the ten loci for WCadjBMI and WHRadjBMI were oppositely associated with BMI, but all three WCnoBMI loci had a consistent association direction with BMI in the GIANT data. In this study, we found no genetic association with WHRnoBMI at loci other than those previously reported (see [Supplementary Table 8](#S1){ref-type="supplementary-material"} online). The variation explained by each newly-identified SNP ranged from 0.02% to 0.09% ([Table 1](#t1){ref-type="table"}, and [Supplementary Table 5](#S1){ref-type="supplementary-material"} online). There were no Stage II replication data for some of the loci because they were identified after the second round of Stage I GWAS data were added to the meta-analysis due to the expansion of the AGEN, which occurred after the original 33 replication SNPs were selected.

Additional analyses examined effect sizes for differences across sex and population. Analyses stratified by sex ([Table 2](#t2){ref-type="table"}, and [Supplementary Table 5](#S1){ref-type="supplementary-material"} online) revealed that association of rs3791679 near the *EFEMP1* gene with WCadjBMI was significantly stronger among men than among women (effect size: 4.04 vs 2.43, *P* for homogeneity test = 0.04), and association of rs1982963 near the *NID2* gene with WHRadjBMI was significantly weaker among men than among women (effect size: 2.88 vs 6.26, *P* for homogeneity test = 0.009). No significant heterogeneity across populations of Chinese, Korean, Japanese, or Filipino was found for the newly-identified loci (data not shown).

[Supplementary Table 7](#S1){ref-type="supplementary-material"} online shows the association of the newly-identified loci with different obesity-related traits. The three novel loci (*CEP120, TSC22D2*, and *SLC22A2*) for WCnoBMI were much less significantly associated with WCadjBMI; the newly-identified loci for WCadjBMI or WHRadjBMI were either unassociated with BMI (*EFEMP1, CNPY2, GNAS*, and *HLA-DRB5*) or negatively associated with BMI (*ADAMTSL3* and *NID2*). Of these 11 loci for WCadjBMI and WHRadjBMI, ten had an opposite association direction with BMI. Using the Wald test of whether the BMI-adjusted effect was equal to its expectation proposed by Aschard *et al.*[@b17], we found Bonferroni-corrected significant p-values (0.05/11) for rs11103390 at *QSOX2* (WCadjBMI) and rs1982963 at *NID2* (WHRadjBMI), suggesting that the associations of these two SNPs with WCadjBMI or WHRadjBMI may have been influenced by their direct genetic association with BMI. The newly-identified seven loci for WCadjBMI were all moderately or strongly associated with height and the three novel loci for WCnoBMI were also moderately associated with height. None of 14 newly-identified loci were associated with diabetes at P \< 0.004 (0.05/14).

Previous studies have reported about 60 genetic loci associated with abdominal obesity[@b2][@b3][@b4][@b5][@b6][@b7][@b8][@b9][@b10][@b11][@b12][@b13] and about 100 genetic loci associated with overall obesity[@b15][@b16][@b18], with the majority of those loci being identified in populations of European ancestry. In those studies, the reported associations with WHR were generally adjusted for BMI, while the reported associations with WC were not adjusted for BMI in most studies. Due to the close correlation (r = 0.83 based on data from the Shanghai genome-wide association studies (SGWAS)) between WC and BMI, there was substantial overlap between loci that were associated with WC and BMI. In the current study, we evaluated the associations of those reported loci with WCadjBMI, WHRadjBMI, WCnoBMI, and WHRnoBMI. The associations with at least one trait that achieved a Bonferroni-corrected significance level (*P* \< 0.05/60 ≈1.0 × 10^−3^) and the associations by sex are shown in [Supplementary Tables 8](#S1){ref-type="supplementary-material"} to [11](#S1){ref-type="supplementary-material"} online (for WCadjBMI, WHRadjBMI, WCnoBMI, and WHRnoBMI, respectively). We found that 23 previously-reported loci for abdominal obesity were significantly associated with WCadjBMI (see [Supplementary Table 11](#S1){ref-type="supplementary-material"} online) and/or WHRadjBMI (see [Supplementary Table 10](#S1){ref-type="supplementary-material"} online) and 18 previously-reported BMI/WC loci were significantly associated with WCnoBMI, among men or women or both at *P* \< 1.0 × 10^−3^ (see [Supplementary Table 9](#S1){ref-type="supplementary-material"} online). Of note, 17 of those 18 loci associated with WCnoBMI were not significantly associated with WCadjBMI. The only SNP demonstrating significant association with WCadjBMI was rs12229654, at our previously-identified Asian-specific BMI locus *MYL2*. Consistent with previous findings[@b7][@b19], we observed that 10 out of 23 replicated genetic loci for abdominal obesity showed significant sex differences (*P* for homogeneity test  \< 0.05), 9 of which showed larger effects in women than men (see [Supplementary Table 10](#S1){ref-type="supplementary-material"} online). In contrast, 4 replicated WCnoBMI loci revealed significant sex differences, 3 of which showed larger effects in men (see [Supplementary Table 9](#S1){ref-type="supplementary-material"} online). It is worth noting that the SNP rs12229654 at *MYL2* and its related SNP rs671 at *ALDH2* were associated with every obesity trait analyzed (WCadjBMI, WHRadjBMI, WCnoBMI, and WHRnoBMI), with larger effects observed in men.

We examined the modification effect of alcohol consumption on the association between the two SNPs in the 12q24 region[@b16] (rs12229654 and rs671) and WC/WHR using data from the SGWAS, for which we had direct access to individual data. We found that the effects of the SNP rs12229654 on WC and WHR, with or without adjustment for BMI, were mainly observed among non-drinkers ([Supplementary Table 13](#S1){ref-type="supplementary-material"} online). The sex-difference of rs671 effect on WC and WHR is less evident.

We evaluated putative functional significance for each newly-identified locus using the Encyclopedia of DNA Elements (ENCODE) and expression quantitative trait locus (eQTL) databases[@b20]. Three of these novel SNPs, rs3809128 near *CNPY2*, rs2057291 at *GNAS*, and rs3791679 near *EFEMP1*, were predicted to be functional as they are located either in promoter or enhancer regions based on epigenomic data from the ENCODE project. The ChromHMM annotation on nine ENCODE cell lines have revealed that the SNP rs3809128 resides in an active promoter of the nearest gene, canopy FGF signaling regulator 2 (*CNPY2*). The DNase and ChIP-Seq has revealed that the SNP rs3809128 is present in the DNase I hypersensitive site (DHS) and in the binding regions of multiple transcription factors (TFs). In particular, this variant has been shown to be associated with the expression of *CNYP2* based on a previous eQTL study[@b19]. The SNP rs2057291 is located in intron 2 of the gene *GNAS*. A search of RegulomeDB[@b21] indicates that this variant is annotated to the TF SRF predicted motif. This variant was also observed to be present in the DHS and multiple TFs peaks. The SNP rs3791679 is located in the first intron of the gene *EFEMP1* and resides in an enhancer region. According to RegulomeDB annotation, the SNP rs3791679 lies in the TF POU3F2 predicted motif. In addition, the DHS and the TF STAT3 peak were found to harbor the variant. Other potential functional variants which are in strong linkage disequilibrium (LD)(r^2^ \> 0.6) with the newly-identified SNPs are listed in [Supplementary Table 12](#S1){ref-type="supplementary-material"} online.

We conducted two separate functional enrichment analyses for genes located near the newly- and previously-identified loci for WC or WHR, one for the loci associated with WCadjBMI and/or WHRadjBMI, another for the loci associated with WCnoBMI. The corticotropin-releasing hormone signaling (*P* = 5.72 × 10^−4^) pathway and Gonadotropin Releasing Hormone (GNRH) signaling (*P* = 8.63 × 10^−4^) pathway, were found to be the most significantly enriched for the loci associated with WCadjBMI and/or WHRadjBMI; and the CDK5 signaling (*P* = 1.66 × 10^−4^) and corticotropin-releasing hormone signaling (*P* = 2.21 × 10^−4^) pathway were significantly enriched for the loci associated with WCnoBMI.

Discussion
==========

Previously-reported genetic loci associated with WC, mainly from studies conducted in European-ancestry populations, were generally not adjusted for BMI. There was substantial overlapping between loci that were associated with WC and BMI due to high correlation between those two measurements. Three novel SNPs (rs10051787 near *CEP120*, rs1868673 near *TSC22D2*, and rs368123 at *SLC22A2*), newly identified for WCnoBMI in this study, did not reach the genome-wide significance level in our previous meta-analysis for BMI, and thus were not identified as the BMI loci. After adjustment for BMI, the association of these three SNPs with WCadjBMI was substantially attenuated. In addition, our study showed that previously-reported genetic loci for WC or BMI were generally not significantly associated with WCadjBMI (see [Supplementary Table 11](#S1){ref-type="supplementary-material"} online), suggesting that these two highly-correlated anthropometrics capture a similar biological phenotype. On the other hand, the genetic loci associated with WCadjBMI and/or WHRadjBMI were not typically associated with BMI or showed an opposite association direction (see [Supplementary Table 7](#S1){ref-type="supplementary-material"} and [Supplementary Table 14](#S1){ref-type="supplementary-material"} online). These findings reveal differences in genetic predisposition to overall as opposed to abdominal obesity, as well as the genetic regulation of body fat distribution versus BMI.

Two newly-identified WCadjBMI-related loci (*EFEMP1, ADAMTSL3*) and the newly-identified WCnoBMI-related loci (*CEP120*) were previously reported to affect height as well[@b11][@b22], suggesting these loci may be related to general body frame size. The SNP rs3791679 near *EFEMP1* seems particularly relevant to WC and height. *EFEMP1* encodes an extracellular matrix protein containing tandemly-repeated epidermal growth factor-like repeats, which are able to stimulate DNA synthesis and are involved in cell proliferation[@b23]. *EFEMP1* knockout mice exhibited reduced reproductivity, and displayed an early onset of aging-associated phenotypes including reduced lifespan and decreased body mass[@b24]. A recent study showed that the *EFEMP1* locus affected growth rate in children[@b25].

Another newly-identified WCnoBMI-related SNP, rs1868673, resides near the gene *TSC22D2*. A recent study indicated that this locus was associated with circulating levels of adiponectin, a hormone produced predominantly by adipocytes[@b26].

We previously reported the association of two related SNPs in the 12q24 region (rs12229654 at gene *MYL2* and rs671 at *ALDH2*, r^2^ = 0.58)[@b15][@b16], a specific polymorphic region for East Asian-ancestry populations, with BMI. This association was significantly stronger among men than among women. We observed similar associations of those SNPs with WC and WHR, with or without adjustment for BMI ([Supplementary Tables 8](#S1){ref-type="supplementary-material"} to [11](#S1){ref-type="supplementary-material"} online). The sex differences of associations were more prominent for WHR. The SNPs rs12229654 and rs671 have been reported to be associated with HDL cholesterol[@b27], levels of gamma glutamyl transpeptidase[@b27], elevated blood pressure[@b28], lower risk of coronary heart disease[@b29] and alcohol consumption[@b30] in Asian-ancestry populations. Our previous study[@b16] suggested an antagonistic effect of alcohol consumption on the *ALDH2*-BMI association. The *ALDH2\*1* BMI-increasing effect was mainly observed among non-drinkers. In this study, we found that the effects of the SNP rs12229654 at *MYL2* on WC and WHR, with or without adjustment for BMI, were mainly seen among non-drinkers ([Supplementary Table 13](#S1){ref-type="supplementary-material"} online).

Consistent with previous reports from European populations, we found evidence for multiple loci with significant sex differences for abdominal obesity in East Asians, with a generally more prominent effect in women, although larger effects in men than in women were observed for loci *EFEMP1*, *MYL2/ALDH2*, and *FGFR4*. Typically, men have more visceral fat, whereas women have more subcutaneous fat. It is well known that sex hormones play an important role in the regulation of body fat distribution[@b31], but the underlying genetic mechanisms remain unclear. It would be worthwhile to investigate the association between these genetic loci and sex hormone levels.

The corticotropin-releasing hormone signaling (*P* = 5.72 × 10^−4^) pathway and Gonadotropin Releasing Hormone (GNRH) signaling (*P* = 8.63 × 10^−4^) pathway were found to be significantly enriched for genes associated with WCadjBMI and/or WHRadjBMI loci in this study. The corticotropin-releasing hormone signaling (*P* = 5.72 × 10^−4^) pathway was found to be related to BMI in our previous report for BMI loci[@b16]. Corticotrophin-releasing hormone causes release of adrenocorticotropic hormone from the pituitary gland. Its main role in the body is as the central driver of the stress hormone system, known as the hypothalamic-pituitary-adrenal axis. Gonadotrophin-releasing hormone plays a key role in coordinating the levels of hormones in the hypothalamic-pituitary-gonadal axis; these hormones act on the testes and ovaries to initiate and maintain their reproductive functions. These results provide additional evidence affirming the involvement of stress and sex hormones in obesity and fat distribution.

Recently, Aschard *et al.*[@b17] raised a concern that adjusting for BMI may bias genetic effects on WC/WHR and observed enrichment of SNPs that were associated with WC/WHR and BMI in the opposite directions, as shown in the Heid *et al.* study[@b7] and in our study (see [Supplementary Table 5](#S1){ref-type="supplementary-material"} online). As shown in the results section, the associations of SNPs rs11103390 at *QSOX2* with WCadjBMI or rs1982963 at *NID2* with WHRadjBMI may be influenced by their direct genetic association with BMI. Further studies are warranted to evaluate this influence.

Another limitation of this study is lack of replication data for some SNPs identified in the expanded Stage I study which will need to be confirmed in future studies.

In conclusion, our study identified at the genome-wide significance level four novel loci near the *EFEMP1*, *ADAMTSL3, CNPY2*, and *GNAS* genes that are associated with WCadjBMI, two loci near the *NID2* and *HLA-DRB5* genes that were associated with WHRadjBMI, and three novel loci near the *CEP120*, *TSC22D2*, and *SLC22A2* genes that were associated with WCnoBMI. Of about 60 genetic loci previously identified for abdominal obesity in predominantly European populations, a similar association was found in our study for 23 in East Asians, suggesting Asian- and European-ancestry individuals have both a shared and a unique genetic basis for abdominal obesity. Functional analyses suggest that genetic regulation for abdominal fat distribution may occur via the corticotropin-releasing hormone signaling, GNRH signaling, and/or CDK5 signaling pathway.

Materials and Methods
=====================

Study design
------------

This study had two stages. Stage I was a meta-analysis of study-specific results on the association between SNPs and WC or WHR from GWAS that participated in the Asian Genetic Epidemiology Network (AGEN) Consortium. Stage II conducted *de novo* or *in silico* replication analyses to further examine the association for some promising SNPs selected from the Stage I meta-analysis. [Supplementary Tables 1](#S1){ref-type="supplementary-material"},[2](#S1){ref-type="supplementary-material"},[3](#S1){ref-type="supplementary-material"} online and the [Supplementary Information](#S1){ref-type="supplementary-material"} page online summarize the basic data for all participating studies.

Stage I samples and genotyping
------------------------------

In stage I, the participating GWAS were recruited in two rounds because of the expansion of the AGEN. The first round included eight GWAS with a total 27,537 (for WC) or 25,241 (for WHR) individuals of East Asian ancestry, and the second round included eight more GWAS with a total 17,072 (for WC) or 14,628 (for WHR) individuals of East Asian ancestry. In addition, Stage I analysis included about 50,000 SNPs with minor allele frequency over 1% from 8,443 subjects with genotyping data by exome-chip. Therefore, the total sample sizes in Stage I were 53,052 for WC and 48,312 for WHR.

The sample sizes of the 16 participating GWAS in Stage I varied from 695 to 9,279, comprising a total of 44,596 individuals. Nine studies used Affymetrix arrays, and seven studies used the Illumina platform (detailed information is provided in the [Supplementary Information](#S1){ref-type="supplementary-material"} online). To allow for combination of the data derived from different genotyping platforms and to improve coverage of the genome, genotype imputation was performed by each participating study using either MACH or IMPUTE with HapMap CHB+JPT data (release \#22, build 36) as the imputation reference panel (see [Supplementary Table 2](#S1){ref-type="supplementary-material"} online).

Stage I statistical analysis
----------------------------

A uniform statistical analysis protocol was followed by each participating study. To improve the normality of the WC and WHR distribution and alleviate the impact of outliers, rank-based inverse normal transformation (INT) was applied to WC and WHR data separately for each sex by each study. INT involves ranking all WC and WHR values, transforming these ranks into quantiles and, finally, converting the resulting quantiles into normal deviates. Associations between SNPs and the inverse normal-transformed WC and WHR were analyzed with a linear regression model, assuming an underlying additive genetic model and adjusting for age (continuous), age-squared, and sex (if applicable). Stratified analyses by sex were also performed for each study. To evaluate the genetic influence on body fat distribution, all the analyses were conducted using two separate models, one with adjustment for BMI, another without adjustment for BMI.

Next, we carried out meta-analyses using a weighted average method with inverse-variance weights. The meta-analyses were carried out on all data combined and also stratified by sex using the freely available METAL software. The presence of heterogeneity across studies and between sexes was tested with Cochran's Q statistics[@b32].

To correct each study for residual population stratification or cryptic relatedness, the meta-analyses were performed with genomic control correction[@b33] by adjusting for the study-specific inflation factor (λ), which ranged from 1.000 to 1.078 in Stage I (see [Supplementary Table 2](#S1){ref-type="supplementary-material"} online). After this adjustment, the estimated inflation factors for the Stage I meta-analysis statistic were 1.053 (WCadjBMI), 1.042 (WHRadjBMI), 1.091 (WCnoBMI), and 1.054 (WHRnoBMI), which were further adjusted for when calculating the Stage I results.

Stage II replication analysis
-----------------------------

We selected 33 SNPs at 33 independent loci with *P* \< 1.00 × 10^−6^ for the associations with WC or WHR for a *de novo* replication (Stage II), based on the GWAS data that were recruited in the first round of Stage I. The replication genotyping was conducted at three study sites (see [Supplementary Table 1](#S1){ref-type="supplementary-material"} online) comprising 3,762 to 17,110 Asian-ancestry individuals based on availability of *de novo* data for each SNP. Participating studies are described in the [Supplementary Information](#S1){ref-type="supplementary-material"} and [Supplementary Tables 1](#S1){ref-type="supplementary-material"} to [3](#S1){ref-type="supplementary-material"} online.

Each study individually conducted a similar analysis of the association of WC and WHR with the selected SNPs, using the same protocol used in Stage I. The Stage II data were combined using the same meta-analysis methods as in Stage I. Finally, we used meta-analysis to combine all data from both Stages I and II.
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###### Newly identified loci associated with waist circumference (WC)/WHR variation in Asian-ancestry populations.

  Nearby gene    Chr      SNP       Alleles[a](#t1-fn1){ref-type="fn"}   EAF[b](#t1-fn2){ref-type="fn"}   StageI*P*   Stage II *P*   Stage I & II     EV(%)[e](#t1-fn5){ref-type="fn"}                
  ------------- ----- ------------ ------------------------------------ -------------------------------- ----------- -------------- -------------- --------------------------------------- ---------- -------
  WCadjBMI                                                                                                                                                                                            
  EFEMP1          2    rs3791679                   A/G                                0.21                1.43E-13      3.63E-02        64454                    2.87(0.38)                 4.86E-14   0.03%
  ADAMTSL3       15    rs8030379                   A/G                                0.76                1.62E-09         NA           50668       2.46(0.41)[f](#t1-fn6){ref-type="fn"}   1.62E-09   0.02%
  CNPY2          12    rs3809128                   C/T                                0.80                3.74E-09         NA           30368                   3.69(0.63)^f^               3.74E-09   0.04%
  GNAS           20    rs2057291                   G/A                                0.73                4.02E-08         NA           38613       2.52(0.46)[f](#t1-fn6){ref-type="fn"}   4.02E-08   0.02%
  WHRadjBMI                                                                                                                                                                                           
  NID2           14    rs1982963                   A/G                                0.81                1.41E-12      1.71E-03        56208                    4.82(0.62)                 1.07E-14   0.07%
  HLA-DRB5        6    rs5020946                   T/G                                0.41                4.38E-09      1.13E-01        49519                    3.15(0.52)                 1.30E-09   0.05%
  WCnoBMI                                                                                                                                                                                             
  CEP120          5    rs10051787                  T/C                                0.40                1.07E-09      1.40E-03        60909                    3.96(0.58)                 7.23E-12   0.08%
  TSC22D2         3    rs1868673                   C/A                                0.48                1.49E-08         NA           36247       4.36(0.77)[f](#t1-fn6){ref-type="fn"}   1.49E-08   0.09%
  SLC22A2         6     rs368123                   G/A                                0.39                1.00E-06      7.29E-03        62430                    3.16(0.57)                 2.64E-08   0.05%

^a^Shown as: effect allele/other allele.

^b^Effect allele frequency in Asian-ancestry populations, estimated from stage I studies.

^c^Per allele effect of SNPs in percentile of standard deviation, derived from meta-analysis.

^d^Derived from meta-analysis. The *P* values for the combined data were adjusted for both study-specific inflation factors and the estimated inflation factor for the stage I meta-analysis statistic.

^e^Explained variance, estimated from combined stage I and II data.

^f^Stage I results are shown.

###### Newly identified loci associated with WC/WHR variation in East Asian-ancestry populations, by gender.

  Nearby gene    Chr      SNP       Alleles   Among men   Among women   Test for homogeneity                                  
  ------------- ----- ------------ --------- ----------- ------------- ---------------------- ------- ------------ ---------- ----------
  WCadjBMI                                                                                                                    
  EFEMP1          2    rs3791679      A/G       21172     4.04(0.63)          1.76E-10         42605   2.43(0.49)   6.31E-07   4.37E-02
  ADAMTSL3       15    rs8030379      A/G       16135     1.41(0.72)          4.89E-02         33848   2.37(0.52)   5.70E-06   2.80E-01
  CNPY           12    rs3809128      C/T       11098     2.08(1.07)          5.15E-02         18575   1.59(0.88)   7.30E-02   7.24E-01
  GNAS           20    rs2057291      G/A       11626     3.10(1.01)          2.15E-03         26302   1.99(0.60)   8.70E-04   3.44E-01
  WHRadjBMI                                                                                                                   
  NID2           14    rs1982963      A/G       17516     2.88(1.04)          5.37E-03         33264   6.26(0.78)   8.88E-16   9.32E-03
  HLA-DRB5        6    rs5020946      T/G       14055     3.17(0.97)          1.10E-03         30049   3.57(0.65)   3.54E-08   7.32E-01
  WCnoBMI                                                                                                                     
  CEP120          5    rs10051787     T/C       20191     4.60(1.00)          4.15E-06         40033   3.82(0.70)   4.89E-08   5.27E-01
  TSC22D2         3    rs1868673      C/A       10742     5.58(1.54)          2.93E-04         24820   4.28(0.91)   2.40E-06   4.67E-01
  SLC22A2         6     rs368123      G/A       21164     2.30(0.97)          1.73E-02         40581   3.64(0.70)   1.91E-07   2.61E-01

Alleles: Shown as effect allele/other allele. β: Effect of SNPs per allele in percentile of standard deviation, derived from meta-analysis. P: Derived from meta-analysis adjusted for both study-specific inflation factors (for stage I, II) and the estimated inflation factor for the stage I meta-analysis statistic.
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